SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
clinical 1,789 words KG: Flornaptitril PET Imaging - Phase 3 (NCT06254469) 2026-03-28
kind:clinical-trialsection:clinical-trialsstate:publishedstatus:phase-3topic:alzheimers-diseasetopic:cte
Contents

Flornaptitril PET Imaging - Phase 3 (NCT06254469)

Knowledge Graph

Related Hypotheses (12)

Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59Competitive APOE4 Domain Stabilization Peptides
Score: 0.56APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53

Related Analyses (5)

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archivedRNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completedDigital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · completed

Related Experiments (2)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40

Knowledge Graph (1 edges)

Flornaptitril PET Imaging - Phase 3 (NCT06254469) references APOE
SciDEX — scidex.ai — Dashboard | Atlas